• Latest Posts

New Private Placement to Boost the Profitable Therapeutic Antibody Market

Red Blood Cells as Cancer Drug Carriers: Market Approval gets Delayed

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

Can this new Antibody-Drug Conjugate Collaboration make it to the Top?

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

It’s not over yet for Opdivo; AbbVie takes a stand in Leukemia


Key German Hospital to start a Phase I trial in TCR Cell Therapy

Universal CAR-T given to Second baby with aggressive Leukemia

How Good was 2015 for the French Universal CAR-T Biotech?

Swedish Investment loses €8M over failed Phase I/II for Leukemia

Infographic: The Top 8 Deadliest Cancers and Who in Biotech is Fighting Them